These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 67887)

  • 21. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells.
    Bisht KS; Bradbury CM; Zoberi I; Curry HA; Kaushal A; Roti Roti JL; Gius D
    Int J Radiat Biol; 2003 Nov; 79(11):879-88. PubMed ID: 14698956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoting effect of bile acids on the chemical transformation of C3H/10T1/2 fibroblasts in vitro.
    Kaibara N; Yurugi E; Koga S
    Cancer Res; 1984 Dec; 44(12 Pt 1):5482-5. PubMed ID: 6498811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of endogenous homocysteine by mouse fibroblast C3H/10T1/2 Cl 8 and the chemically transformed C3H/10T1/2 MCA Cl 16 cells following methotrexate exposure.
    Ueland PM; Refsum H; Male R; Lillehaug JR
    J Natl Cancer Inst; 1986 Jul; 77(1):283-9. PubMed ID: 3459921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A method for the amplification of chemically induced transformation in C3H/10T1/2 clone 8 cells: its use as a potential screening assay.
    Schechtman LM; Kiss E; McCarvill J; Nims R; Kouri RE; Lubet RA
    J Natl Cancer Inst; 1987 Sep; 79(3):487-98. PubMed ID: 3114533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chlorohydroxyfuranones on 3-methylcholanthrene-induced neoplastic transformation in the two-stage transformation assay in C3H 10T1/2 cells.
    Laaksonen M; Mäki-Paakkanen J; Kronberg L; Komulainen H
    Arch Toxicol; 2003 Oct; 77(10):594-600. PubMed ID: 14574448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoplastic transformation in cell cultures: in-vitro/in-vivo correlations.
    Bertram JS
    IARC Sci Publ; 1985; 67():77-91. PubMed ID: 3913645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation of Chinese Hamster V79 cells and transformation and mutation of mouse fibroblast C3H/10T1/2 clone 8 cells by aflatoxin B1 and four other furocoumarins isolated from two Nigerian medicinal plants.
    Uwaifo AO; Billings PC; Heidelberger C
    Cancer Res; 1983 Mar; 43(3):1054-8. PubMed ID: 6402296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview and status of in vitro transformation.
    Sivak A
    J Assoc Off Anal Chem; 1979 Jul; 62(4):889-99. PubMed ID: 387711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of modifiers of microsomal enzymes on chemical oncogenesis in cultures of C3H mouse cell lines.
    Nesnow S; Heidelberger C
    Cancer Res; 1976 May; 36(5):1801-8. PubMed ID: 1268837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal dissociation in the exposure times required for maximal induction of cytotoxicity, mutation, and transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 ClA31-1-1 cell line.
    Bignami M; Ficorella C; Dogliotti E; Norman RL; Kaighn ME; Saffiotti U
    Cancer Res; 1984 Jun; 44(6):2452-7. PubMed ID: 6722787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
    Bertram JS; Faletto MB
    Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the incidence of oncogenic transformation produced by X rays, misonidazole, and chemotherapy agents.
    Hall EJ; Miller RC; Osmak R; Zimmerman M
    Radiology; 1982 Nov; 145(2):521-3. PubMed ID: 6182579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociated occurrence of single-gene mutation and oncogenic transformation in C3H 10T1/2 cells exposed to ultraviolet light and caffeine.
    Chan GL; Little JB
    J Cell Physiol; 1982 Jun; 111(3):309-14. PubMed ID: 7096454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of the morphological transformation of Syrian hamster embryo (SHE) cells by reducing incubation time of the target cells.
    Zhang H; Borman HD; Myhr BC
    Mutat Res; 2004 Apr; 548(1-2):1-7. PubMed ID: 15063130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological transformation and chromosome damage by amsacrine in C3H/10T1/2 clone 8 cells.
    Ferguson LR; van Zijl P; Nesnow S
    Mutat Res; 1986 Jun; 170(3):133-43. PubMed ID: 3754932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of malignant transformation and mutagenesis in cell cultures by cancer chemotherapeutic agents.
    Marquardt H; Marquardt H
    Cancer; 1977 Oct; 40(4 Suppl):1930-4. PubMed ID: 332336
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of chromosomal aberrations, cytotoxicity, and morphological transformation in mammalian cells by the antiparasitic drug flubendazole and the antineoplastic drug harringtonine.
    Huang N; Cerepnalkoski L; Nwankwo JO; Dews M; Landolph JR
    Fundam Appl Toxicol; 1994 Feb; 22(2):304-13. PubMed ID: 8005380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental study on antineoplastic agents causing hematopoietic diseases].
    Miyazaki S; Take H; Nagayama T
    Nihon Shonika Gakkai Zasshi; 1972 Jan; 76(1):38-43. PubMed ID: 4112292
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumoral drugs as possible blastogenic agents the problem of anti-blastic medication.
    Llombart A
    Osterr Z Onkol; 1976 Sep; 3(3):72-7. PubMed ID: 63933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.